MétaCan
Menu
Back to cohort
Record W2969949365 · doi:10.1016/j.bbmt.2019.08.014

Hematopoietic Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Updated 2019 Evidence-Based Review from the American Society for Transplantation and Cellular Therapy

2019· review· en· W2969949365 on OpenAlexaff
Zachariah DeFilipp, Anjali S. Advani, Veronika Bachanová, Ryan D. Cassaday, Daniel J. DeAngelo, Partow Kebriaei, Jacob M. Rowe, Matthew D. Seftel, Wendy Stock, Martin S. Tallman, Suzanne Fanning, Yoshihiro Inamoto, Ankit Kansagra, Laura Johnston, Arnon Nagler, Craig S. Sauter, Bipin N. Savani, Miguel‐Angel Perales, Paul A. Carpenter, Richard A. Larson, Daniel J. Weisdorf

Bibliographic record

VenueBiology of Blood and Marrow Transplantation · 2019
Typereview
Languageen
FieldMedicine
TopicAcute Lymphoblastic Leukemia research
Canadian institutionsUniversity of ManitobaCancerCare Manitoba
FundersAcademy of Nutrition and DieteticsGilead SciencesAbbVieSanofiNovartisVanda PharmaceuticalsGenzymePfizerAmgen
KeywordsMedicineTransplantationHematopoietic stem cell transplantationOncologyIntensive care medicineMinimal residual diseaseChemotherapyDiseaseGrading (engineering)Consensus conferenceRandomized controlled trialHematopoietic cellLeukemiaInternal medicineStem cellHaematopoiesis

Abstract

fetched live from OpenAlex

The role of hematopoietic cell transplantation (HCT) in adults with acute lymphoblastic leukemia (ALL) is reviewed and critically evaluated in this systematic evidence-based review. Specific criteria were used for searching the published literature and for grading the quality and strength of the evidence and the strength of the recommendations. A panel of ALL experts developed consensus on the treatment recommendations based on the evidence. Allogeneic HCT offers a survival benefit in selected patients with ALL, and this review summarizes the standard indications as well as the areas of controversy. There is now greater experience with pediatric-inspired chemotherapy regimens that has transformed upfront therapy for adult ALL, resulting in higher remission rates and overall survival. This in turn has increased the equipoise around decision making for ALL in first complete remission (CR1) when there is no measurable residual disease (MRD) at the end of induction and/or consolidation. Randomized studies are needed for adults with ALL to compare allogeneic HCT in CR1 with pediatric-inspired chemotherapy alone. Indications for transplantation in the evolving landscape of MRD assessments and novel targeted and immune therapeutics remain important areas of investigation.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.004
Threshold uncertainty score0.015

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.003
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0030.002
Bibliometrics0.0040.004
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0040.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.038
GPT teacher head0.319
Teacher spread0.281 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSystematic review
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations123
Published2019
Admission routes1
Has abstractno

Explore more

Same venueBiology of Blood and Marrow TransplantationSame topicAcute Lymphoblastic Leukemia researchFrench-language works237,207